Walmart DOJ Opioid Settlement (August 2026)
Walmart agreed to pay $50 million to resolve a similar DOJ lawsuit over opioid dispensing, far less than CVS's $315 million settlement. The difference in scale reflects the specific allegations and company size.
Walmart avoided prolonged litigation and further reputational damage.
The settlement reinforced the DOJ's pattern of pursuing pharmacy chains for opioid dispensing.
Shows the range of federal opioid settlements, with CVS at the higher end.
